Orange County Register

Botox maker Allergan is popular with mutual funds and pension funds, despite worries that the economy will limit the Irvine-based company’s revenue growth.

A total of 637 institutional investors own Allergan shares, according to Mutual Fund Facts About Individual Stocks.

The top holder is Fidelity Investments, with 33.9 million shares, although it and another 171 institutional investors cut back on their holdings of Allergan shares as of the fund’s latest filing with the Securities and Exchange Commission, MFFAIS says.

But at the same time 210 other institutional investors added to their storepiles of Allergan shares.

At $52.78, Allergan shares are down 15 percent from a year ago.

Related links:

• Botox is feeling the effects of slowing economy
• Economy nips at O.C. plastic surgery
• Priscilla’s face divides cosmetic docs; what about you?
• Botox can reach the brain, researchers say
• Botox news coverage may boost injections by doctors

For more on cosmetic medicine, see list of links on right-hand side of this blog.

You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.